Class A shares of the biomedical plate rose, Rip Bio rose more than 8%, * ST Xianfeng rose more than 3.5%, Kexing Pharmaceutical, Oriental Bio, Pre-Science Bio, Azure Bio and so on rose.
Microsoft (MSFT. O) expects revenue from its Azure business to increase by 34% to 35% in the fiscal fourth quarter.
Microsoft (MSFT. O): Mandatory multi-factor authentication (MFA) for Azure users will be rolled out in phases in the second half of 2024.
Microsoft Azure: The issue with the Azure Front Door has been fully resolved, affecting some Microsoft services worldwide.
Microsoft's (MSFT. O) AI services contributed 8% to Azure's revenue growth, up from 7% previously.
Microsoft Azure: Unexpected usage spikes caused some initial problems.
According to market news, Microsoft Azure has announced that it is investigating issues affecting the Azure portal.